markets is the sole category represented across all 2 tracked stories. Sun Pharma is most often covered alongside Ajay Bagga, which appears in 2 of these 2 stories. They are better corroborated than the beat average, carrying 6.5 original sources each against 4.2 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Sun Pharma
markets is the sole category represented across all 2 tracked stories. Sun Pharma is most often covered alongside Ajay Bagga, which appears in 2 of these 2 stories. They are better corroborated than the beat average, carrying 6.5 original sources each against 4.2 for the same window. The 7-day window averages about 2 stories each week. Their average consequence score of 5.5 runs below the beat's 6.4 for that window. This profile follows 2 Finance stories mentioning Sun Pharma across the period from July 10, 2026 to July 16, 2026.
Stories tracked
2
Per week
2
Sources per story
6.5
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 101 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Sun Pharma. Shared-story counts are live from our verified record — not editorial picks.
Indian equities opened higher despite a 12% weekly oil spike and Middle East turmoil. The Sensex added 266 points and Nifty held above 24,100, powered by IT and consumer durables. While PSU banks and realty slipped, gold steadied on dovish Fed bets.
Indian equity markets surged on July 10, 2026, with Sensex gaining over 700 points to trade at 77,441.52 and Nifty reclaiming the 24,000 level. The Nifty IT index led the rally with a 2.08% jump, buoyed by strong earnings expectations and positive global cues, while gold and crude reflected a nuanced risk environment.